Teladoc Health Review
Teladoc Health (NYSE: TDOC) is the largest telehealth company in the United States by patient volume. Founded in 2002 and publicly traded since 2015, Teladoc merged with chronic condition management platform Livongo in 2020 — creating a broad virtual care ecosystem that now spans primary care, behavioral health, dermatology, and chronic disease management.
Quick Facts
| Starting Price | Contact provider |
| Medications | 2 peptides |
| Consultation | Hybrid |
| Shipping | 3-5 business days |
| Lab Testing | Not included |
| Prescriber | licensed physicians. |
Teladoc Health offers 2 peptides for GLP-1 therapy. Teladoc Health (NYSE: TDOC) is the largest telehealth company in the United States by patient volume. Founded in 2002 and publicly traded since 2015, Teladoc merged with chronic condition management platform Livongo in 2020 — creating a broad virtual care ecosystem that now spans primary care, behavioral health, dermatology, and chronic disease management.
Pros & Cons
What We Like
- Largest telehealth platform in the US with proven infrastructure and nationwide availability
- Integrated chronic condition management
- Brand-name GLP-1 medications and orforglipron available
- Video consultations (not async-only)
- Broadest insurance network in telehealth
- Behavioral health integration
Watch Out For
- Weight management program launched in 2024
- Providers are general practitioners, not obesity medicine specialists
- Combined membership and medication cost is high ($224/mo for orforglipron) compared to focused competitors
- Weight loss is one of many services, not the primary focus
- Mixed patient satisfaction reviews for the weight management program specifically
- No tirzepatide cash-pay option currently listed
Pricing Breakdown
Pricing not yet verified for Teladoc Health. Visit their site for current pricing →
Medications Offered
2 peptides available through Teladoc Health.
Semaglutide
weight-loss · Subcutaneous injection (weekly)
A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely prescribed for weight management. Reduces appetite and slows gastric emptying.
Tirzepatide
weight-loss · Subcutaneous injection (weekly)
A dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes. Clinical trials show significant weight reduction, often exceeding semaglutide results.
Considering Teladoc Health?
Request a free, no-obligation consultation. We'll share your details with Teladoc Healthand they'll reach out within 1–2 business days.
Patient Reviews
No patient reviews on Telehealth Ally yet. Be the first to review Teladoc Health
Used Teladoc Health? Help others decide.
Leave your email and we'll send you a short, 3-minute review form. Your honest experience helps the next patient make a better choice.
We'll only email you once about this review. No spam. Write a review now
How Teladoc Health Compares
See how Teladoc Health stacks up against other GLP-1 providers.
Provider Comparisons
Medication Comparisons
Ready to explore Teladoc Health?
Based on our independent review, Teladoc Health offers 2 peptides for GLP-1 therapy. Request a free consultation or visit their site to get started.
Telehealth Ally may receive compensation when you request a consultation. This does not affect our rankings or reviews.
Get weekly GLP-1 pricing updates
We track prices so you don't have to.
No spam. Unsubscribe anytime.
How We Review Providers
Our editorial team independently evaluates every telehealth provider based on pricing transparency, medication availability, clinical protocols, and patient experience. We verify pricing data weekly and update reviews when providers change their offerings. Revenue never influences our rankings or recommendations.
Read our editorial standards →